Apolipoprotein E e4 allele frequency in patients with multiple system atrophy (Q36856567)

16 August 2017

Apolipoprotein E e4 allele frequency in patients with multiple system atrophy (English)

1 reference

16 August 2017

4

Lees AJ

1 reference

16 August 2017

1

Cairns NJ

1 reference

16 August 2017

6

Lantos PL

1 reference

16 August 2017

Atkinson PF

2

1 reference

16 August 2017

Kovács T

series ordinal

3

1 reference

16 August 2017

Daniel SE

series ordinal

5

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

16 August 2017

4

1 reference

inferred from page(s)

published in

Neuroscience Letters

1 reference

16 August 2017

221

1 reference

16 August 2017

2-3

1 reference

16 August 2017

161-164

1 reference

Statement on Use of Apolipoprotein E Testing for Alzheimer Disease

16 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913316-4

7 January 2021

The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. The French Research Group on Epidemiology of Human Spongiform Encephalopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913316-4

7 January 2021

Apolipoprotein E gene in diffuse Lewy body disease with or without co-existing Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913316-4

7 January 2021

Apolipoprotein E allele distribution in parents of Down's syndrome children.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913316-4

7 January 2021

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913316-4

7 January 2021

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913316-4

7 January 2021

Alzheimer's disease with and without coexisting Parkinson's disease changes: apolipoprotein E genotype and neuropathologic correlates.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913316-4

7 January 2021

Regional Variation in the Distribution of Apolipoprotein E and Aβ in Alzheimerʼs Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913316-4

7 January 2021

Clinical and pathological correlates of apolipoprotein E ?4 in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913316-4

7 January 2021

Apolipoprotein E type ϵ4 allele frequency is increased in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913316-4

7 January 2021

Cellular pathology of multiple system atrophy: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913316-4

7 January 2021

Confirmation of association between the e4 allele of apolipoprotein E and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913316-4

7 January 2021

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913316-4

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913316-4

7 January 2021

Apolipoprotein E ε4 allele is associated with deposition of amyloid β-protein following head injury

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913316-4

7 January 2021

Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913316-4

7 January 2021

Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913316-4

7 January 2021

Apolipoprotein E allelic frequencies in patients with lobar atrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913316-4

7 January 2021

Apolipoprotein E and B alleles in Parkinson's patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913316-4

7 January 2021

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913316-4

7 January 2021

Apolipoprotein E in sporadic and familial Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913316-4

7 January 2021

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913316-4

7 January 2021

Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913316-4

7 January 2021

The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913316-4

7 January 2021

Apolipoprotein E genotyping by one-stage PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913316-4

7 January 2021

Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913316-4

7 January 2021

Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913316-4

7 January 2021

10.1016/S0304-3940(96)13316-4

Identifiers

DOI

1 reference

16 August 2017

1 reference